Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Deficiency in Patients With Persistent Symptoms Following Concussion

NCT05660356 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05660356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05660356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Deficiency in Patients With Persistent Symptoms Following Concussion
Lead sponsor
University of Calgary
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2023
Completion date
February 28, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

concussion post syndrome, concussion, mild, growth hormone deficiency, growth hormone treatment